Prof Holgate's letter published in FT today - shown below1 Feb 2021 06:57
Without wishing to puncture anybody’s optimism, Anjana Ahuja is quite right to argue in her column (Opinion, January 26) that vaccines are being oversold as a strategy to exit the pandemic.
It is unrealistic to believe that a virus mutating as rapidly as Covid-19 can be defeated through prevention alone.
Even once “herd immunity” is achieved, new variants are likely to circulate within the population. In addition to effective contact tracing, quarantine and isolation, the key to unlocking the population is to find effective treatments that prevent people from becoming seriously ill.
The US government’s Operation Warp Speed is accelerating development of promising treatments including inhaled interferon beta — a naturally occurring protein investigated at my own university, the University of Southampton.
This treatment can prevent the progression of any virus-induced lung damage once someone is infected in contrast to preventing infection (which vaccines do).
It is time for other governments, including the UK’s, to emulate this approach by placing as much national priority behind development of treatments as has successfully been deployed behind distribution of vaccines.
Sir Stephen T Holgate
Medical Research Council Clinical Professor of Immunopharmacology
Faculty of Medicine, Clinical and Experimental Sciences
University of Southampton
Southampton, UK